Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proton Pump Inhibitors | 7 | 2024 | 552 | 1.860 |
Why?
|
Colorectal Neoplasms | 19 | 2023 | 6960 | 1.380 |
Why?
|
Hepatitis B, Chronic | 8 | 2019 | 412 | 1.220 |
Why?
|
Colonic Polyps | 4 | 2021 | 557 | 0.890 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2016 | 294 | 0.870 |
Why?
|
Feces | 7 | 2024 | 1503 | 0.860 |
Why?
|
Adenomatous Polyps | 2 | 2021 | 109 | 0.860 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 140 | 0.790 |
Why?
|
Sulfur Compounds | 1 | 2021 | 32 | 0.750 |
Why?
|
Diverticulitis | 5 | 2024 | 187 | 0.720 |
Why?
|
Bacteria | 3 | 2021 | 2209 | 0.670 |
Why?
|
Diet | 14 | 2024 | 8085 | 0.660 |
Why?
|
Health Occupations | 1 | 2020 | 226 | 0.630 |
Why?
|
Adenoma | 7 | 2020 | 2155 | 0.620 |
Why?
|
Anti-Bacterial Agents | 9 | 2023 | 7476 | 0.610 |
Why?
|
Hepatitis B virus | 6 | 2016 | 530 | 0.570 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.570 |
Why?
|
Cultural Diversity | 1 | 2020 | 370 | 0.540 |
Why?
|
Hepatitis B | 2 | 2013 | 708 | 0.530 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2023 | 2428 | 0.530 |
Why?
|
Sulfur | 3 | 2021 | 158 | 0.530 |
Why?
|
Vaccination | 3 | 2022 | 3425 | 0.480 |
Why?
|
Alanine Transaminase | 3 | 2015 | 608 | 0.480 |
Why?
|
Prospective Studies | 40 | 2024 | 54798 | 0.460 |
Why?
|
Precancerous Conditions | 1 | 2021 | 975 | 0.460 |
Why?
|
Self Report | 9 | 2022 | 3768 | 0.420 |
Why?
|
Metagenomics | 6 | 2024 | 473 | 0.410 |
Why?
|
Metagenome | 5 | 2024 | 464 | 0.410 |
Why?
|
Irritable Bowel Syndrome | 3 | 2023 | 454 | 0.410 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3099 | 0.400 |
Why?
|
Feeding Behavior | 4 | 2021 | 3210 | 0.400 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3222 | 0.400 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2021 | 2327 | 0.390 |
Why?
|
Sulfur-Reducing Bacteria | 2 | 2021 | 14 | 0.380 |
Why?
|
Health Personnel | 5 | 2021 | 3386 | 0.380 |
Why?
|
Hepatitis C, Chronic | 3 | 2019 | 1032 | 0.380 |
Why?
|
Incidence | 17 | 2022 | 21501 | 0.370 |
Why?
|
Biomedical Research | 2 | 2021 | 3457 | 0.360 |
Why?
|
Middle Aged | 63 | 2024 | 223016 | 0.350 |
Why?
|
Liver Cirrhosis | 4 | 2017 | 1959 | 0.340 |
Why?
|
Life Style | 2 | 2021 | 3929 | 0.340 |
Why?
|
United States | 30 | 2024 | 72896 | 0.320 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1203 | 0.320 |
Why?
|
Risk Factors | 32 | 2023 | 74853 | 0.320 |
Why?
|
Adult | 57 | 2024 | 223055 | 0.310 |
Why?
|
Humans | 106 | 2024 | 765823 | 0.310 |
Why?
|
Dietary Fiber | 3 | 2024 | 767 | 0.300 |
Why?
|
Sweden | 5 | 2023 | 1381 | 0.280 |
Why?
|
Pandemics | 10 | 2022 | 8698 | 0.280 |
Why?
|
Liver Neoplasms | 6 | 2021 | 4351 | 0.270 |
Why?
|
Blastocystis | 2 | 2024 | 21 | 0.270 |
Why?
|
Female | 67 | 2024 | 396050 | 0.260 |
Why?
|
Aged | 44 | 2024 | 171178 | 0.260 |
Why?
|
Follow-Up Studies | 19 | 2023 | 39226 | 0.260 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1353 | 0.260 |
Why?
|
Cesarean Section | 2 | 2023 | 1418 | 0.250 |
Why?
|
Male | 59 | 2024 | 363740 | 0.240 |
Why?
|
Age of Onset | 3 | 2021 | 3341 | 0.240 |
Why?
|
Hepacivirus | 2 | 2011 | 1343 | 0.240 |
Why?
|
Brain Ischemia | 1 | 2017 | 3001 | 0.230 |
Why?
|
Risk Assessment | 9 | 2021 | 24278 | 0.230 |
Why?
|
Case-Control Studies | 10 | 2024 | 22227 | 0.220 |
Why?
|
Time Factors | 10 | 2024 | 40109 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8601 | 0.210 |
Why?
|
Antiviral Agents | 5 | 2015 | 3051 | 0.210 |
Why?
|
Cohort Studies | 13 | 2024 | 41643 | 0.210 |
Why?
|
Multivariate Analysis | 8 | 2021 | 12056 | 0.200 |
Why?
|
Propionates | 1 | 2023 | 180 | 0.200 |
Why?
|
Diet Surveys | 3 | 2021 | 1159 | 0.200 |
Why?
|
Postprandial Period | 2 | 2021 | 319 | 0.200 |
Why?
|
Vitamin D-Binding Protein | 1 | 2023 | 129 | 0.200 |
Why?
|
Butyrates | 1 | 2023 | 162 | 0.200 |
Why?
|
Ageusia | 1 | 2021 | 18 | 0.190 |
Why?
|
Dementia | 1 | 2016 | 2743 | 0.190 |
Why?
|
Proportional Hazards Models | 8 | 2021 | 12520 | 0.190 |
Why?
|
Health Surveys | 3 | 2021 | 4058 | 0.180 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 2184 | 0.180 |
Why?
|
Public Health | 3 | 2021 | 2678 | 0.180 |
Why?
|
Hepatitis C | 1 | 2011 | 1596 | 0.180 |
Why?
|
Data Collection | 2 | 2020 | 3317 | 0.180 |
Why?
|
Adenoma, Villous | 1 | 2020 | 13 | 0.170 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.170 |
Why?
|
Cough | 2 | 2021 | 597 | 0.170 |
Why?
|
Obesity | 6 | 2024 | 13078 | 0.170 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 147 | 0.170 |
Why?
|
Disease Notification | 1 | 2020 | 95 | 0.170 |
Why?
|
Colonoscopy | 5 | 2021 | 1408 | 0.160 |
Why?
|
Defecation | 1 | 2021 | 190 | 0.160 |
Why?
|
Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
Hepatitis B e Antigens | 3 | 2015 | 135 | 0.160 |
Why?
|
Dyspnea | 3 | 2021 | 1351 | 0.160 |
Why?
|
Masks | 1 | 2021 | 209 | 0.150 |
Why?
|
Tooth Loss | 1 | 2020 | 198 | 0.150 |
Why?
|
Career Mobility | 1 | 2020 | 259 | 0.150 |
Why?
|
Age Factors | 7 | 2021 | 18380 | 0.150 |
Why?
|
Rifamycins | 1 | 2017 | 27 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 402 | 0.150 |
Why?
|
Young Adult | 15 | 2023 | 59849 | 0.140 |
Why?
|
Fruit | 2 | 2021 | 1167 | 0.140 |
Why?
|
Vegetables | 2 | 2021 | 1200 | 0.140 |
Why?
|
Biodiversity | 1 | 2020 | 344 | 0.140 |
Why?
|
Diet, Mediterranean | 2 | 2021 | 746 | 0.140 |
Why?
|
Fever | 2 | 2021 | 1603 | 0.140 |
Why?
|
Progestins | 1 | 2019 | 300 | 0.140 |
Why?
|
Periodontal Diseases | 1 | 2020 | 453 | 0.130 |
Why?
|
Nurses | 4 | 2021 | 2505 | 0.130 |
Why?
|
DNA, Viral | 4 | 2016 | 2199 | 0.130 |
Why?
|
Nursing Research | 1 | 2017 | 80 | 0.130 |
Why?
|
Specimen Handling | 1 | 2021 | 703 | 0.130 |
Why?
|
Television | 1 | 2019 | 409 | 0.130 |
Why?
|
Siblings | 1 | 2020 | 828 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 698 | 0.130 |
Why?
|
Social Justice | 1 | 2020 | 484 | 0.130 |
Why?
|
Microsatellite Instability | 1 | 2019 | 728 | 0.130 |
Why?
|
Communicable Disease Control | 1 | 2022 | 856 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 388 | 0.130 |
Why?
|
Stroke | 1 | 2017 | 9749 | 0.120 |
Why?
|
Peritonitis | 1 | 2017 | 368 | 0.120 |
Why?
|
Weight Gain | 3 | 2023 | 2355 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Inflammation | 4 | 2023 | 10845 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1208 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2022 | 59506 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 751 | 0.120 |
Why?
|
Health Status | 3 | 2021 | 4084 | 0.110 |
Why?
|
Population Surveillance | 2 | 2021 | 2595 | 0.110 |
Why?
|
Adolescent | 12 | 2022 | 88794 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1432 | 0.110 |
Why?
|
Gastroesophageal Reflux | 1 | 2021 | 833 | 0.110 |
Why?
|
Energy Intake | 1 | 2021 | 2141 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1405 | 0.100 |
Why?
|
Depression | 2 | 2023 | 8224 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 695 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1349 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7840 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1206 | 0.100 |
Why?
|
Cognition | 2 | 2022 | 7045 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12235 | 0.100 |
Why?
|
Comorbidity | 3 | 2018 | 10570 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1184 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1527 | 0.100 |
Why?
|
Liver Failure | 1 | 2014 | 252 | 0.100 |
Why?
|
Liver Transplantation | 2 | 2014 | 2417 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1297 | 0.090 |
Why?
|
Biopsy | 2 | 2020 | 6765 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2443 | 0.090 |
Why?
|
Prebiotics | 1 | 2021 | 41 | 0.090 |
Why?
|
Mental Health | 2 | 2022 | 3271 | 0.090 |
Why?
|
Prevotella | 2 | 2021 | 81 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9441 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3237 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7599 | 0.080 |
Why?
|
Blood Glucose | 2 | 2021 | 6422 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3557 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1387 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1914 | 0.080 |
Why?
|
Sex Factors | 6 | 2021 | 10607 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26276 | 0.080 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 370 | 0.080 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2009 | 222 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2283 | 0.080 |
Why?
|
Carcinoma | 1 | 2020 | 2312 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15398 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2531 | 0.070 |
Why?
|
Viremia | 1 | 2011 | 727 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3656 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15881 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3734 | 0.070 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15645 | 0.070 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 168 | 0.070 |
Why?
|
Constipation | 2 | 2023 | 568 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2013 | 2350 | 0.070 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 1039 | 0.070 |
Why?
|
Probiotics | 1 | 2021 | 387 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3987 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2656 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4670 | 0.070 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2009 | 482 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12800 | 0.070 |
Why?
|
Fungi | 1 | 2019 | 347 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2010 | 910 | 0.070 |
Why?
|
Health | 1 | 2019 | 397 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3815 | 0.060 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2020 | 1042 | 0.060 |
Why?
|
Software | 1 | 2020 | 4458 | 0.060 |
Why?
|
Prognosis | 4 | 2021 | 29915 | 0.060 |
Why?
|
Cause of Death | 3 | 2022 | 3710 | 0.060 |
Why?
|
Mutation | 3 | 2019 | 30188 | 0.060 |
Why?
|
Viruses | 1 | 2019 | 370 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4424 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7581 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 1188 | 0.060 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.060 |
Why?
|
Bilophila | 1 | 2024 | 12 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15832 | 0.060 |
Why?
|
Blastocystis Infections | 1 | 2024 | 17 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.060 |
Why?
|
Barrett Esophagus | 1 | 2008 | 494 | 0.060 |
Why?
|
Vitamins | 2 | 2023 | 1631 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1788 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2017 | 3966 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2022 | 81505 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13613 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 134 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 100 | 0.050 |
Why?
|
Safety | 2 | 2021 | 1158 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 398 | 0.050 |
Why?
|
Phylogeny | 1 | 2019 | 2835 | 0.050 |
Why?
|
Odds Ratio | 3 | 2021 | 9653 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5786 | 0.050 |
Why?
|
Fusobacterium | 1 | 2021 | 56 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5837 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2021 | 99 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 84 | 0.050 |
Why?
|
California | 3 | 2010 | 1436 | 0.040 |
Why?
|
Food Microbiology | 1 | 2021 | 73 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2021 | 150 | 0.040 |
Why?
|
Body Weight | 2 | 2023 | 4624 | 0.040 |
Why?
|
Taste Disorders | 1 | 2020 | 37 | 0.040 |
Why?
|
Fast Foods | 1 | 2022 | 220 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
Hunger | 1 | 2021 | 207 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2021 | 304 | 0.040 |
Why?
|
Israel | 1 | 2021 | 725 | 0.040 |
Why?
|
Vitamin D | 2 | 2023 | 3272 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2023 | 798 | 0.040 |
Why?
|
Mass Screening | 3 | 2022 | 5445 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 466 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1717 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3412 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11838 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 390 | 0.040 |
Why?
|
Body Mass Index | 3 | 2022 | 13041 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 223 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13635 | 0.040 |
Why?
|
Metabolome | 1 | 2024 | 1005 | 0.030 |
Why?
|
Pregnancy | 2 | 2023 | 30215 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1247 | 0.030 |
Why?
|
Hyperplasia | 1 | 2020 | 1146 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2022 | 7119 | 0.030 |
Why?
|
Diarrhea | 1 | 2023 | 1315 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 520 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1187 | 0.030 |
Why?
|
Exercise | 2 | 2023 | 5937 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3427 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2023 | 945 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 560 | 0.030 |
Why?
|
Ascites | 1 | 2017 | 336 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 65223 | 0.030 |
Why?
|
Intestines | 1 | 2024 | 1907 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1127 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 493 | 0.030 |
Why?
|
Obesity, Abdominal | 1 | 2018 | 370 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 696 | 0.030 |
Why?
|
Metabolomics | 1 | 2024 | 1668 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1605 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 832 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1101 | 0.030 |
Why?
|
Waist Circumference | 1 | 2018 | 934 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14644 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2036 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1551 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1885 | 0.020 |
Why?
|
Viral Load | 2 | 2012 | 3385 | 0.020 |
Why?
|
Genotype | 3 | 2012 | 13023 | 0.020 |
Why?
|
Hemodynamics | 1 | 2022 | 4188 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1738 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1967 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22349 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1471 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1892 | 0.020 |
Why?
|
Risk | 1 | 2023 | 9600 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6320 | 0.020 |
Why?
|
Texas | 1 | 2010 | 410 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3851 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4849 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1883 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4332 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42478 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1444 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2910 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3563 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6252 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2191 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10723 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5873 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2415 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3947 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9355 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12821 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2008 | 358 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16706 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5508 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14745 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 16040 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2643 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8320 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9520 | 0.010 |
Why?
|
Child | 2 | 2021 | 80509 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10087 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6489 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36375 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11205 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168730 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14062 | 0.010 |
Why?
|
Concepts
(308)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_